 | • レポートコード：GIR201113185 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、リポソームドラッグデリバリーの世界市場を調査対象にし、リポソームドラッグデリバリーの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）、用途別分析（真菌感染症治療、癌及び腫瘍治療、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Gilead Sciences、CSPC、Johnson & Johnson、Pacira、Ipsen (Onivyde)、Sun Pharmaceutical、Novartis、Sigma-Tau、Luye Pharma、Teva Pharmaceutical、Fudan-Zhangjiang ・メーカー別販売量、売上、市場シェア ・リポソームドラッグデリバリーの地域別市場分析 ・リポソームドラッグデリバリーの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・リポソームドラッグデリバリーのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・リポソームドラッグデリバリーのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・リポソームドラッグデリバリーの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・リポソームドラッグデリバリーの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・リポソームドラッグデリバリーの種類別市場規模2015-2020：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 ・リポソームドラッグデリバリーの用途別市場規模2015-2020：真菌感染症治療、癌及び腫瘍治療、その他 ・リポソームドラッグデリバリーの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Liposome Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Liposome Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 5473.4 million by 2025, from USD 3447.6 million in 2019.
Market segmentation
Liposome Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liposome Drug Delivery market has been segmented into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
By Application, Liposome Drug Delivery has been segmented into:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liposome Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Liposome Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liposome Drug Delivery market.
The report offers in-depth assessment of the growth and other aspects of the Liposome Drug Delivery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liposome Drug Delivery Market Share Analysis
Liposome Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liposome Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liposome Drug Delivery sales, revenue and market share for each player covered in this report.
The major players covered in Liposome Drug Delivery are:
Gilead Sciences
CSPC
Johnson & Johnson
Pacira
Ipsen (Onivyde)
Sun Pharmaceutical
Novartis
Sigma-Tau
Luye Pharma
Teva Pharmaceutical
Fudan-Zhangjiang
Among other players domestic and global, Liposome Drug Delivery market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposome Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposome Drug Delivery, with price, sales, revenue and global market share of Liposome Drug Delivery in 2018 and 2019.
Chapter 3, the Liposome Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposome Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liposome Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liposome Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Liposome Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liposome Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Liposome Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Overview of Global Liposome Drug Delivery Market
1.4.1 Global Liposome Drug Delivery Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CSPC
2.2.1 CSPC Details
2.2.2 CSPC Major Business
2.2.3 CSPC SWOT Analysis
2.2.4 CSPC Product and Services
2.2.5 CSPC Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pacira
2.4.1 Pacira Details
2.4.2 Pacira Major Business
2.4.3 Pacira SWOT Analysis
2.4.4 Pacira Product and Services
2.4.5 Pacira Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ipsen (Onivyde)
2.5.1 Ipsen (Onivyde) Details
2.5.2 Ipsen (Onivyde) Major Business
2.5.3 Ipsen (Onivyde) SWOT Analysis
2.5.4 Ipsen (Onivyde) Product and Services
2.5.5 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sun Pharmaceutical
2.6.1 Sun Pharmaceutical Details
2.6.2 Sun Pharmaceutical Major Business
2.6.3 Sun Pharmaceutical Product and Services
2.6.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Product and Services
2.7.4 Novartis Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sigma-Tau
2.8.1 Sigma-Tau Details
2.8.2 Sigma-Tau Major Business
2.8.3 Sigma-Tau Product and Services
2.8.4 Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Luye Pharma
2.9.1 Luye Pharma Details
2.9.2 Luye Pharma Major Business
2.9.3 Luye Pharma Product and Services
2.9.4 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business
2.10.3 Teva Pharmaceutical Product and Services
2.10.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Fudan-Zhangjiang
2.11.1 Fudan-Zhangjiang Details
2.11.2 Fudan-Zhangjiang Major Business
2.11.3 Fudan-Zhangjiang Product and Services
2.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liposome Drug Delivery Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liposome Drug Delivery Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liposome Drug Delivery Manufacturer Market Share in 2019
3.3.2 Top 6 Liposome Drug Delivery Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liposome Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Liposome Drug Delivery Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liposome Drug Delivery Revenue and Market Share by Regions (2015-2020)
4.2 North America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.3 Europe Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.5 South America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liposome Drug Delivery Sales, Revenue and Market Share by Country
5.1.1 North America Liposome Drug Delivery Sales and Market Share by Country (2015-2020)
5.1.2 North America Liposome Drug Delivery Revenue and Market Share by Country (2015-2020)
5.2 United States Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.3 Canada Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.4 Mexico Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liposome Drug Delivery Sales, Revenue and Market Share by Country
6.1.1 Europe Liposome Drug Delivery Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liposome Drug Delivery Revenue and Market Share by Country (2015-2020)
6.2 Germany Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.3 UK Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.4 France Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.5 Russia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.6 Italy Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liposome Drug Delivery Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liposome Drug Delivery Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liposome Drug Delivery Revenue and Market Share by Regions (2015-2020)
7.2 China Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.3 Japan Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.4 Korea Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.5 India Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.7 Australia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liposome Drug Delivery Sales, Revenue and Market Share by Country
8.1.1 South America Liposome Drug Delivery Sales and Market Share by Country (2015-2020)
8.1.2 South America Liposome Drug Delivery Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liposome Drug Delivery Sales and Growth Rate (2015-2020)
8.3 Argentina Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liposome Drug Delivery Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liposome Drug Delivery Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liposome Drug Delivery Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.3 Turkey Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.4 Egypt Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.5 South Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liposome Drug Delivery Sales and Market Share by Type (2015-2020)
10.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2015-2020)
10.3 Global Liposome Drug Delivery Price by Type (2015-2020)
11 Global Liposome Drug Delivery Market Segment by Application
11.1 Global Liposome Drug Delivery Sales Market Share by Application (2015-2020)
11.2 Global Liposome Drug Delivery Revenue Market Share by Application (2015-2020)
11.3 Global Liposome Drug Delivery Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liposome Drug Delivery Sales, Revenue and Growth Rate (2021-2025)
12.2 Liposome Drug Delivery Market Forecast by Regions (2021-2025)
12.2.1 North America Liposome Drug Delivery Market Forecast (2021-2025)
12.2.2 Europe Liposome Drug Delivery Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liposome Drug Delivery Market Forecast (2021-2025)
12.2.4 South America Liposome Drug Delivery Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liposome Drug Delivery Market Forecast (2021-2025)
12.3 Liposome Drug Delivery Market Forecast by Type (2021-2025)
12.3.1 Global Liposome Drug Delivery Sales Forecast by Type (2021-2025)
12.3.2 Global Liposome Drug Delivery Market Share Forecast by Type (2021-2025)
12.4 Liposome Drug Delivery Market Forecast by Application (2021-2025)
12.4.1 Global Liposome Drug Delivery Sales Forecast by Application (2021-2025)
12.4.2 Global Liposome Drug Delivery Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liposome Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liposome Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liposome Drug Delivery Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Liposome Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Liposome Drug Delivery Major Business
Table 10. Gilead Sciences Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 11. Gilead Sciences SWOT Analysis
Table 12. Gilead Sciences Liposome Drug Delivery Product and Services
Table 13. Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. CSPC Basic Information, Manufacturing Base and Competitors
Table 15. CSPC Liposome Drug Delivery Major Business
Table 16. CSPC Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 17. CSPC SWOT Analysis
Table 18. CSPC Liposome Drug Delivery Product and Services
Table 19. CSPC Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 21. Johnson & Johnson Liposome Drug Delivery Major Business
Table 22. Johnson & Johnson Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 23. Johnson & Johnson SWOT Analysis
Table 24. Johnson & Johnson Liposome Drug Delivery Product and Services
Table 25. Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pacira Basic Information, Manufacturing Base and Competitors
Table 27. Pacira Liposome Drug Delivery Major Business
Table 28. Pacira Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 29. Pacira SWOT Analysis
Table 30. Pacira Liposome Drug Delivery Product and Services
Table 31. Pacira Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Ipsen (Onivyde) Basic Information, Manufacturing Base and Competitors
Table 33. Ipsen (Onivyde) Liposome Drug Delivery Major Business
Table 34. Ipsen (Onivyde) Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 35. Ipsen (Onivyde) SWOT Analysis
Table 36. Ipsen (Onivyde) Liposome Drug Delivery Product and Services
Table 37. Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceutical Liposome Drug Delivery Major Business
Table 40. Sun Pharmaceutical Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 41. Sun Pharmaceutical SWOT Analysis
Table 42. Sun Pharmaceutical Liposome Drug Delivery Product and Services
Table 43. Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Novartis Basic Information, Manufacturing Base and Competitors
Table 45. Novartis Liposome Drug Delivery Major Business
Table 46. Novartis Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 47. Novartis SWOT Analysis
Table 48. Novartis Liposome Drug Delivery Product and Services
Table 49. Novartis Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Sigma-Tau Basic Information, Manufacturing Base and Competitors
Table 51. Sigma-Tau Liposome Drug Delivery Major Business
Table 52. Sigma-Tau Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 53. Sigma-Tau SWOT Analysis
Table 54. Sigma-Tau Liposome Drug Delivery Product and Services
Table 55. Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Luye Pharma Liposome Drug Delivery Major Business
Table 58. Luye Pharma Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 59. Luye Pharma SWOT Analysis
Table 60. Luye Pharma Liposome Drug Delivery Product and Services
Table 61. Luye Pharma Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 63. Teva Pharmaceutical Liposome Drug Delivery Major Business
Table 64. Teva Pharmaceutical Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 65. Teva Pharmaceutical SWOT Analysis
Table 66. Teva Pharmaceutical Liposome Drug Delivery Product and Services
Table 67. Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 69. Fudan-Zhangjiang Liposome Drug Delivery Major Business
Table 70. Fudan-Zhangjiang Liposome Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 71. Fudan-Zhangjiang SWOT Analysis
Table 72. Fudan-Zhangjiang Liposome Drug Delivery Product and Services
Table 73. Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Liposome Drug Delivery Sales by Manufacturer (2018-2019) (K Vial)
Table 75. Global Liposome Drug Delivery Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Liposome Drug Delivery Sales by Regions (2015-2020) (K Vial)
Table 77. Global Liposome Drug Delivery Sales Market Share by Regions (2015-2020)
Table 78. Global Liposome Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Liposome Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 80. North America Liposome Drug Delivery Sales Market Share by Countries (2015-2020)
Table 81. North America Liposome Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Liposome Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 83. Europe Liposome Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 84. Europe Liposome Drug Delivery Sales Market Share by Countries (2015-2020)
Table 85. Europe Liposome Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Liposome Drug Delivery Sales by Regions (2015-2020) (K Vial)
Table 87. Asia-Pacific Liposome Drug Delivery Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Liposome Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Liposome Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 90. South America Liposome Drug Delivery Sales Market Share by Countries (2015-2020)
Table 91. South America Liposome Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Liposome Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Liposome Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 94. Middle East & Africa Liposome Drug Delivery Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Liposome Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 97. Global Liposome Drug Delivery Sales by Type (2015-2020) (K Vial)
Table 98. Global Liposome Drug Delivery Sales Share by Type (2015-2020)
Table 99. Global Liposome Drug Delivery Revenue by Type (2015-2020) (USD Million)
Table 100. Global Liposome Drug Delivery Revenue Share by Type (2015-2020)
Table 101. Global Liposome Drug Delivery Sales by Application (2015-2020) (K Vial)
Table 102. Global Liposome Drug Delivery Sales Share by Application (2015-2020)
Table 103. Global Liposome Drug Delivery Sales Forecast by Regions (2021-2025) (K Vial)
Table 104. Global Liposome Drug Delivery Market Share Forecast by Regions (2021-2025)
Table 105. Global Liposome Drug Delivery Sales Forecast by Type (2021-2025) (K Vial)
Table 106. Global Liposome Drug Delivery Market Share Forecast by Type (2021-2025)
Table 107. Global Liposome Drug Delivery Sales Forecast by Application (2021-2025)
Table 108. Global Liposome Drug Delivery Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liposome Drug Delivery Picture
Figure 2. Global Sales Market Share of Liposome Drug Delivery by Type in 2019
Figure 3. Liposomal Doxorubicin Picture
Figure 4. Liposomal Amphoteracin B Picture
Figure 5. Liposomal Paclitaxel Picture
Figure 6. Others Picture
Figure 7. Liposome Drug Delivery Sales Market Share by Application in 2019
Figure 8. Fungal Infection Therapy Picture
Figure 9. Cancer & Tumor Therapy Picture
Figure 10. Others Picture
Figure 11. Global Liposome Drug Delivery Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Liposome Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Liposome Drug Delivery Sales Market Share by Manufacturer in 2019
Figure 32. Global Liposome Drug Delivery Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Liposome Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Liposome Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 37. Global Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Liposome Drug Delivery Revenue Market Share by Regions (2015-2020)
Figure 39. Global Liposome Drug Delivery Revenue Market Share by Regions in 2018
Figure 40. North America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
Figure 41. Europe Liposome Drug Delivery Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Liposome Drug Delivery Sales and Growth Rate (2015-2020)
Figure 43. South America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020)
Figure 45. North America Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Liposome Drug Delivery Sales Market Share by Countries (2015-2020)
Figure 47. North America Liposome Drug Delivery Sales Market Share by Countries in 2018
Figure 48. North America Liposome Drug Delivery Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Liposome Drug Delivery Revenue Market Share by Countries in 2018
Figure 50. United States Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 51. Canada Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 52. Mexico Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 53. Europe Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Liposome Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Liposome Drug Delivery Revenue Market Share by Countries in 2019
Figure 56. Germany Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 57. UK Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 58. France Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 59. Russia Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 60. Italy Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 61. Asia-Pacific Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Liposome Drug Delivery Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Regions 2019
Figure 64. China Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 65. Japan Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 66. Korea Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 67. India Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 68. Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 69. South America Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Liposome Drug Delivery Sales Market Share by Countries in 2019
Figure 71. South America Liposome Drug Delivery Revenue Market Share by Countries in 2019
Figure 72. Brazil Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 73. Argentina Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 74. Middle East and Africa Liposome Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Liposome Drug Delivery Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 79. Egypt Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 80. Turkey Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 81. South Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 82. Global Liposome Drug Delivery Sales and Growth Rate (2021-2025) (K Vial)
Figure 83. Global Liposome Drug Delivery Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Liposome Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 85. Europe Sales Liposome Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 86. Asia-Pacific Sales Liposome Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 87. South America Sales Liposome Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 88. Middle East & Africa Sales Liposome Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
鼻腔内薬物送達デバイスの世界市場 2020年 Market Overview The Intranasal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- ポリエチレングリコールリポソームドコルビシンの世界市場 2020年 Market Overview The Pegylated Liposomal Docorubicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- バイオ医薬品ドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioph…
- スマートドラッグデリバリードローンの世界市場 2020年 Market Overview The global Smart Drug Delivery Drones market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Drug Deliver…
- 埋め込み型無針薬物デリバリーの世界市場 2020年 Market Overview The global Implantable and Needle-Free Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Imp…